- Phos >4.5 mg/dL. Most common cause: kidney failure (AKI or CKD).
- First: is it real? Hemolyzed sample, paraprotein, high lipids or bilirubin, heparin/tPA in the line can fake it.
- Acute and high (TLS, rhabdo, Fleet enema) → the danger is low calcium and Ca-P crystals in the kidney.
- Acute: stop the source, IV fluids if kidneys and heart allow, dialysis if severe with AKI or symptomatic low Ca.
- Do not give calcium for asymptomatic low Ca when phos is very high. Give it for tetany, seizures, arrhythmia or long QT.
- Chronic CKD: cut phosphate additives, give a binder WITH meals, limit calcium-based binders.
Pathophysiology in 60 seconds
⌄
- We eat ~1000–1400 mg of phosphate a day. The gut absorbs most of it; the kidney removes the same amount.
- When GFR falls below ~30, the kidney cannot keep up (even with high FGF23 and PTH pushing it out) → phosphate rises.
- High phosphate binds calcium → low ionized Ca (tetany, long QT, seizures) and Ca-P crystals in vessels, skin, heart valves and kidney tubules.
- In CKD, chronic high phos → high PTH, vascular calcification, and higher mortality.
Push phosphate up and ionized calcium goes down — the extra Ca-P precipitates in tissues. Giving IV calcium to a patient with very high phos adds more crystals: do it only for symptoms.
Calcium and phosphate are like salt and water in a pot. Add too much of either and crystals fall out — in arteries, in the skin (calciphylaxis) and in the kidney tubules (acute phosphate nephropathy).
Symptoms
- Most come from low calcium: perioral numbness, cramps, tetany, Chvostek/Trousseau, prolonged QT, seizures, hypotension.
- Acute kidney injury (crystals in tubules) — TLS, oral sodium phosphate bowel prep.
- Chronic: itching, vascular and valve calcification, calciphylaxis (painful necrotic skin lesions), renal osteodystrophy.
Causes
⌄
- Fleet (sodium phosphate) enema in old, CKD, dehydrated or constipated/obstructed patients → phos can go >20 mg/dL, severe low Ca, death.
- Oral sodium phosphate bowel prep → acute phosphate nephropathy (FDA boxed warning). Use PEG prep in CKD, elderly, ACEi/ARB/diuretic users.
- IV phosphate in a patient with a low GFR.
Diagnosis
⌄
- Repeat if unexpected — non-hemolyzed, no line contamination.
- Labs: BMP (creatinine), Ca (ionized if possible), Mg, K, uric acid, LDH, CK, glucose, ABG/lactate if acidotic.
- ECG — QTc.
- Chronic: PTH, 25-OH vitamin D, alkaline phosphatase.
- High phos + low PTH + normal creatinine → hypoparathyroidism (often after neck surgery).
Normal kidneys can clear huge amounts. If phos is high with a normal GFR, someone gave it (enema, IV, vitamin D), cells broke (TLS, rhabdo, hemolysis), acidosis shifted it out, or the PTH is missing.
Management
⌄
- Stop phosphate sources: enemas, IV phos, phosphate-containing TPN/IV fluids, vitamin D.
- IV fluids (isotonic) → more renal excretion. Only if kidneys work and no volume overload. It can lower Ca further — watch.
- Treat the cause: TLS bundle (fluids, rasburicase for urate), rhabdo (fluids), acidosis (insulin in DKA shifts phos back in).
- Binders with any oral intake (sevelamer is safe in AKI).
- Calcium: only for symptoms (tetany, seizure, arrhythmia, long QT) → calcium gluconate 1–2 g IV. Asymptomatic low Ca → do not (more crystals).
- Dialysis: severe hyperphos with AKI, oliguria, or symptomatic low Ca. In TLS, phos rebounds → frequent or continuous therapy.
- KDIGO 2017: lower elevated phos toward normal. Avoid high calcium. No strict Ca × P product target any more.
- Diet (with a renal dietitian): the enemy is phosphate additives — almost 100% absorbed (vs ~40–60% from plants).
- Avoid: dark colas, processed/deli meats, fast food, processed cheese, many frozen and "enhanced" meats. Look for "PHOS" on the label (sodium phosphate, phosphoric acid…).
- Plant protein is better than processed meat. Do not starve protein in dialysis patients.
- Dialysis: longer or more frequent sessions remove more phosphate.
- Treat high PTH (calcitriol/analog, cinacalcet) together with phos — CKD-MBD team.
All binders work only if taken WITH meals. Start dose with each meal (TID), titrate by the phos level.
| Binder | Start dose | Good | Watch out |
|---|---|---|---|
| Calcium acetate (667 mg cap) | 2 caps TID with meals | Cheap, works | High Ca, calcification — limit elemental Ca ≤1500 mg/day |
| Calcium carbonate | 500 mg–1 g Ca TID | Cheap, OTC | Same; needs stomach acid (PPI ↓) |
| Sevelamer carbonate (800 mg) | 800–1600 mg TID | No Ca, no metal, lowers LDL | Pill burden, GI upset; binds some drugs |
| Lanthanum (chewable 500–1000 mg) | 500 mg TID | Strong, fewer pills | Must chew; GI upset; shows on X-ray |
| Ferric citrate (1 g tab) | 2 tabs TID | Also gives iron | Dark stools, diarrhea, iron overload |
| Sucroferric oxyhydroxide (500 mg chewable) | 500 mg TID | Low pill burden | Dark stools, diarrhea |
| Tenapanor (not a binder) | 30 mg BID before breakfast/dinner | Blocks gut absorption (NHE3); add-on for dialysis | Diarrhea |
| ~~Aluminum hydroxide~~ | Short term only | Very strong | Aluminum toxicity — avoid long term |
The binder must meet the food in the gut. A binder taken at bedtime binds nothing. Skip the meal → skip the binder. Snacks with protein → a binder dose too.
Doses are typical adult starting doses. Titrate to the phos level, and check Ca and PTH. Acute severe hyperphosphatemia needs nephrology.
Real-life ward tips
⌄
- "Phos 9, patient looks fine, Cr normal" → check for a hemolyzed sample or paraprotein (myeloma) before you treat.
- Never order a Fleet enema for a patient with CKD, AKI, ileus or an obstruction. Use a PEG or mineral-oil option.
- Dialysis patient admitted: continue the home binder with meals — and hold it when NPO. Check the binder is on the MAR with meals, not "TID" at random times.
- TLS: watch phos, K, Ca, uric acid, creatinine every 6–8 h for the first 24–72 h after chemo starts.
- Low Ca + high phos in AKI: correct only if symptomatic. Many "low" Ca are low albumin — check ionized Ca.
- Calcium acetate + calcium carbonate + vitamin D in one patient = a recipe for hypercalcemia and calcification. Review the home list.
- Rhabdo: phos is high early, Ca low early and high later (recovery) — another reason not to give Ca unless symptomatic.
Pitfalls
⌄
- Treating a pseudohyperphosphatemia (paraprotein, hemolysis, heparin/tPA in sample).
- IV calcium for asymptomatic low Ca with very high phos → metastatic calcification.
- Binder at bedtime or while NPO.
- Fleet enema / oral sodium phosphate prep in CKD or elderly.
- Ignoring phosphate additives — "I don't eat dairy" but drinks 3 colas a day.
- Using aluminum binders long term.
Board corner
⌄
| Stem | Answer |
|---|---|
| Elderly CKD patient, Fleet enema, phos 18, Ca 5.8, QTc 520 | Phosphate enema toxicity → IV Ca (symptomatic) + dialysis |
| Lymphoma, day 2 of chemo: high K, phos, urate; low Ca; AKI | Tumor lysis syndrome |
| AKI 1 week after oral sodium phosphate colonoscopy prep | Acute phosphate nephropathy |
| High phos, low Ca, low PTH, after thyroidectomy | Hypoparathyroidism |
| High phos, low Ca, high PTH, normal kidneys, short 4th metacarpal | Pseudohypoparathyroidism (PTH resistance) |
| Phos 8, normal Cr, IgG kappa M-spike, no symptoms | Pseudohyperphosphatemia (paraprotein) |
| Dialysis, phos 7.2, Ca 10.4 on calcium acetate | Switch to a non-calcium binder (sevelamer, lanthanum, iron-based) |
| Dialysis + iron deficiency + high phos | Ferric citrate |
| Painful necrotic skin lesions in a dialysis patient | Calciphylaxis |
| Best time to take a binder | With meals |
References
⌄
- KDIGO 2017 Clinical Practice Guideline Update for CKD–Mineral and Bone Disorder. Kidney Int Suppl. 2017;7:1.
- Leaf DE, Wolf M. A physiologic-based approach to the evaluation of a patient with hyperphosphatemia. Am J Kidney Dis. 2013;61:330.
- Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int. 2009;76:1027.
- Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3.
- Kalantar-Zadeh K, et al. Understanding sources of dietary phosphorus in the treatment of patients with CKD. Clin J Am Soc Nephrol. 2010;5:519.
- FDA approval of tenapanor (Xphozah) as add-on therapy for hyperphosphatemia in dialysis, October 2023.